Insufficient Control of Blood Pressure and Incident Diabetes
暂无分享,去创建一个
Raffaele Izzo | Marcello Chinali | G. de Simone | B. Trimarco | Guido Iaccarino | R. Izzo | F. Rozza | Giovanni de Simone | Guido Iaccarino | V. Trimarco | Bruno Trimarco | Renata Giudice | Valentina Trimarco | Nicola De Luca | Francesco Rozza | M. Chinali | Renata Giudice | N. De Luca
[1] C. Dollery,et al. Glucose Tolerance During Antihypertensive Therapy in Patients with Diabetes Mellitus , 1985, Hypertension.
[2] Masafumi Matsuda,et al. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.
[3] Michael M Engelgau,et al. Elevated blood pressure among U.S. adults with diabetes, 1988-1994. , 2002, American journal of preventive medicine.
[4] H. Aburatani,et al. Angiotensin II–Induced Insulin Resistance Is Associated With Enhanced Insulin Signaling , 2002, Hypertension.
[5] L. Wilhelmsen,et al. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up , 2007, Journal of hypertension.
[6] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[7] O. Arcucci,et al. Association of suboptimal blood pressure control with body size and metabolic abnormalities , 2007, Journal of hypertension.
[8] Raffaele Izzo,et al. The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis , 2005, Journal of hypertension.
[9] R. Devereux,et al. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study , 2007, Journal of Human Hypertension.
[10] G. Reboldi,et al. New-onset diabetes, antihypertensive treatment, and outcome. , 2007, Hypertension.
[11] B. Trimarco,et al. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. , 1992, The Journal of clinical investigation.
[12] G. D. Johnston,et al. A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM , 1995, Diabetologia.
[13] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[14] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[15] F. Nieto,et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .
[16] Paul Mitchell,et al. Retinal Arteriolar Narrowing Predicts Incidence of Diabetes , 2008, Diabetes.
[17] P. Raskin,et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. , 2004, JAMA.
[18] O. Arcucci,et al. beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene. , 2005, The pharmacogenomics journal.
[19] G. Bray,et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. , 2008, The American journal of clinical nutrition.
[20] Samia Mora,et al. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. , 2007, European heart journal.
[21] M. Welsh,et al. Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter. , 2007, American journal of physiology. Endocrinology and metabolism.
[22] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[23] S. Hallan,et al. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] O. Arcucci,et al. β-Blockade and increased dyslipidemia in patients bearing Glu27 variant of β2 adrenergic receptor gene , 2005, The Pharmacogenomics Journal.
[25] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[26] Piotr Ponikowski,et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.
[27] G. Bakris,et al. Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control. , 2006, QJM : monthly journal of the Association of Physicians.